The pharmaceutical industry has warned against straying from tried-and-tested dosing intervals for Covid-19 vaccines, saying doing so risks public confidence in the shots.
The main pharmaceutical lobby groups in the US and Europe on Wednesday said they supported “adhering to the dosing that has been assessed in clinical trials” and that “emerging discussions regarding dosing strategies” may not be supported by drug labels or published data.
Any changes in dosing and inoculation schedules “should follow the science and be based on a transparent deliberation of the available data”, the International and European Federations of Pharmaceutical Manufacturers & Associations and US industry groups BIO and PhRMA said in a joint statement.
您已阅读23%（739字），剩余77%（2450字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。